Assessment of vaginal health before and after treatment with vaginal suppository containing Lactiplantibacillus pentosus KCA1

Ijeoma Ngozi Ebenebe 1, *, Uduma Eke Osonwa 2, Chidimma Ruth Chukwunwejim 1, Ugonna Chinwe Morikwe 1, Joy Ogugua Igwe 1, Charles O Esimone 1 and Kingsley C Anukam 1, 3, 4.

1 Department of Pharmaceutical Microbiology and Biotechnology, Faculty of Pharmaceutical Sciences, Nnamdi Azikiwe University, Awka, Anambra State, Nigeria.
2 Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Nnamdi Azikiwe University, Awka, Nnewi Campus, Anambra State, Nigeria.
3 Department of Medical Laboratory Science, Faculty of Health Sciences and Technology, Nnamdi Azikiwe University, Awka, Nnewi Campus, Anambra State, Nigeria.
4 Uzobiogene Genomics, London, Ontario, Canada. ORCID iD: 0000-0002-4074-2258
 
Research Article
GSC Biological and Pharmaceutical Sciences, 2021, 17(01), 105–116.
Article DOI: 10.30574/gscbps.2021.17.1.0302
Publication history: 
Received on 31 August 2021; revised on 08 October 2021; accepted on 10 October 2021
 
Abstract: 
Bacterial Vaginosis (BV) is a polymicrobial syndrome characterized by a shift in the vaginal flora from a predominant population of Lactobacilli to a replacement with anaerobes. Vaginal suppositories containing L. pentosus KCA1 were formulated using glycerol-gelatin base. A prospective and follow-up community-based study was done. Vaginal samples were collected from women of reproductive age (non-pregnant) between 18-45 years. A total of 360 women both symptomatic and asymptomatic provided High Vaginal Swabs (HVS) for BV screening using Nugent scoring method and 65 (18.1 %) participants were identified as having BV by microscopy with 45 (12.5 %) of them being consistent with BV (Nugent score of 7-10) and twenty (5.56 %) being intermediate with BV (Nugent score of 4-6). A baseline and intervention questionnaire were administered to the participants. Majority (81.5 %) of the participants affirmed that they have not heard about BV. Social burden reveals that 90.8 % affirmed that they feel frustrated, having BV symptoms recur after treatment and 83.1 % admitted that BV symptoms makes them feel embarrassed, ashamed and dirty. Majority (58.8 %) claimed that the state of their reproductive health is ‘very good’ four weeks after treatment, while 88.2 % of the participants rated their reproductive health after four weeks of treatment to be ‘somewhat better than now than a year ago’. In conclusion, it was revealed that BV has impact on the social status and quality of life of the participants except on their economic status. Knowledge on the awareness of BV among women of reproductive age is essential.
 
Keywords: 
Bacterial Vaginosis; Burden; Reproductive; Participant; Lactiplantibacillus pentosus KCA1; Vaginal Suppository
 
Full text article in PDF: 
Share this